Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: A Markov model to bridge the gap between scientific evidence and clinical practice

Efrat Broide, Adi Eindor-Abarbanel*, Haim Shirin, Vered Richter, Shay Matalon, Moshe Leshno

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: A Markov model to bridge the gap between scientific evidence and clinical practice'. Together they form a unique fingerprint.

Medicine & Life Sciences